TY - JOUR
T1 - Phenotypic and molecular characterisation of CDK13-related congenital heart defects, dysmorphic facial features and intellectual developmental disorders
AU - Members of the Undiagnosed Diseases Network
AU - Bostwick, Bret L.
AU - McLean, Scott
AU - Posey, Jennifer E.
AU - Streff, Haley E.
AU - Gripp, Karen W.
AU - Blesson, Alyssa
AU - Powell-Hamilton, Nina
AU - Tusi, Jessica
AU - Stevenson, David A.
AU - Farrelly, Ellyn
AU - Hudgins, Louanne
AU - Yang, Yaping
AU - Xia, Fan
AU - Wang, Xia
AU - Liu, Pengfei
AU - Walkiewicz, Magdalena
AU - McGuire, Marianne
AU - Grange, Dorothy K.
AU - Andrews, Marisa V.
AU - Hummel, Marybeth
AU - Madan-Khetarpal, Suneeta
AU - Infante, Elena
AU - Coban-Akdemir, Zeynep
AU - Miszalski-Jamka, Karol
AU - Jefferies, John L.
AU - Rosenfeld, Jill A.
AU - Emrick, Lisa
AU - Nugent, Kimberly M.
AU - Lupski, James R.
AU - Belmont, John W.
AU - Lee, Brendan
AU - Lalani, Seema R.
N1 - Funding Information:
Research reported in this manuscript was supported by the NIH Common Fund, through the Office of Strategic Coordination/Office of the NIH Director under Award Number U01 HG007709-01 and NIH/NIGMS T32 GM007526 Medical Genetics Research Fellowship Program. This work was funded in part by the US National Human Genome Research Institute (NHGRI)/National Heart Lung and Blood Institute (NHLBI) grant number UM1HG006542 to the Baylor-Hopkins Center for Mendelian Genomics (BHCMG). JEP was supported by NHGRI K08 HG008986 and the Ting Tsung and Wei Fong Chao Foundation. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
PY - 2017/8/14
Y1 - 2017/8/14
N2 - BACKGROUND: De novo missense variants in CDK13 have been described as the cause of syndromic congenital heart defects in seven individuals ascertained from a large congenital cardiovascular malformations cohort. We aimed to further define the phenotypic and molecular spectrum of this newly described disorder.METHODS: To minimise ascertainment bias, we recruited nine additional individuals with CDK13 pathogenic variants from clinical and research exome laboratory sequencing cohorts. Each individual underwent dysmorphology exam and comprehensive medical history review.RESULTS: We demonstrate greater than expected phenotypic heterogeneity, including 33% (3/9) of individuals without structural heart disease on echocardiogram. There was a high penetrance for a unique constellation of facial dysmorphism and global developmental delay, as well as less frequently seen renal and sacral anomalies. Two individuals had novel CDK13 variants (p.Asn842Asp, p.Lys734Glu), while the remaining seven unrelated individuals had a recurrent, previously published p.Asn842Ser variant. Summary of all variants published to date demonstrates apparent restriction of pathogenic variants to the protein kinase domain with clustering in the ATP and magnesium binding sites.CONCLUSIONS: Here we provide detailed phenotypic and molecular characterisation of individuals with pathogenic variants in CDK13 and propose management guidelines based upon the estimated prevalence of anomalies identified.
AB - BACKGROUND: De novo missense variants in CDK13 have been described as the cause of syndromic congenital heart defects in seven individuals ascertained from a large congenital cardiovascular malformations cohort. We aimed to further define the phenotypic and molecular spectrum of this newly described disorder.METHODS: To minimise ascertainment bias, we recruited nine additional individuals with CDK13 pathogenic variants from clinical and research exome laboratory sequencing cohorts. Each individual underwent dysmorphology exam and comprehensive medical history review.RESULTS: We demonstrate greater than expected phenotypic heterogeneity, including 33% (3/9) of individuals without structural heart disease on echocardiogram. There was a high penetrance for a unique constellation of facial dysmorphism and global developmental delay, as well as less frequently seen renal and sacral anomalies. Two individuals had novel CDK13 variants (p.Asn842Asp, p.Lys734Glu), while the remaining seven unrelated individuals had a recurrent, previously published p.Asn842Ser variant. Summary of all variants published to date demonstrates apparent restriction of pathogenic variants to the protein kinase domain with clustering in the ATP and magnesium binding sites.CONCLUSIONS: Here we provide detailed phenotypic and molecular characterisation of individuals with pathogenic variants in CDK13 and propose management guidelines based upon the estimated prevalence of anomalies identified.
KW - Agenesis of the corpus callosum
KW - CDK13
KW - CHDFIDD
KW - Cyclin-dependent kinase
KW - De novo variant
KW - Developmental delay
KW - Hypertelorism
KW - Neurodevelopmental disorders
KW - Undiagnosed Diseases Network
UR - http://www.scopus.com/inward/record.url?scp=85028582378&partnerID=8YFLogxK
U2 - 10.1186/s13073-017-0463-8
DO - 10.1186/s13073-017-0463-8
M3 - Article
C2 - 28807008
AN - SCOPUS:85028582378
SN - 1756-994X
VL - 9
SP - 73
JO - Genome medicine
JF - Genome medicine
IS - 1
ER -